2024 Rome, Italy

IV-067 Esmée Vendel
Belimumab Pharmacokinetic Simulations to Select an Appropriate Subcutaneous Dosing Regimen to Treat Paediatric Patients with Active Lupus Nephritis
Thursday 15:00-16:30